Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): A randomised, controlled, open-label, phase 3 trial Academic Article Article uri icon

Overview

MeSH Major

  • Arteries
  • Arteriosclerosis

abstract

  • Bristol-Myers Squibb.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(15)70076-8

PubMed ID

  • 25795410

Additional Document Info

start page

  • 375

end page

  • 84

volume

  • 16

number

  • 4